{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:57:34Z","timestamp":1791849454223,"version":"4.3.4"},"reference-count":77,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1991,2,1]],"date-time":"1991-02-01T00:00:00Z","timestamp":665366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[1991,2]]},"DOI":"10.1378\/chest.99.2.465","type":"journal-article","created":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T18:28:23Z","timestamp":1194460103000},"page":"465-471","source":"Crossref","is-referenced-by-count":342,"title":["Toxic Hepatitis with Isoniazid and Rifampin"],"prefix":"10.1016","volume":"99","author":[{"given":"Malcolm A.","family":"Steele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond F.","family":"Burk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger M.","family":"DesPrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.99.2.465_bib1","first-page":"1072","article-title":"Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin","volume":"133","author":"Sarma","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.1953.63690010014007i","article-title":"Toxic hepatitis with jaundice occurring in a patient treated with isoniazid","volume":"152","author":"Randolph","year":"1953","journal-title":"JAMA"},{"key":"10.1378\/chest.99.2.465_bib3","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.1961.63040230013013b","article-title":"Fatal hepatic necrosis secondary to isoniazid therapy","volume":"176","author":"Cohen","year":"1961","journal-title":"JAMA"},{"issue":"2","key":"10.1378\/chest.99.2.465_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2008-1040725","article-title":"Isoniazid-induced liver disease","volume":"1","author":"Maddrey","year":"1981","journal-title":"Seminars in Liver Disease"},{"key":"10.1378\/chest.99.2.465_bib5","first-page":"28","article-title":"Controlled chemoprophylaxis trials in tuberculosis. A general review","volume":"26","author":"Ferebee","year":"1970","journal-title":"Bibl Tuberc"},{"key":"10.1378\/chest.99.2.465_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0041-3879(62)80066-X","article-title":"Long-term chemotherapy in the treatment of chronic pulmonary tuberculosis with cavitation","volume":"43","year":"1962","journal-title":"Tubercle"},{"key":"10.1378\/chest.99.2.465_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.36.2.146","article-title":"Isoniazid and PAS toxicity in 513 cases","volume":"36","author":"Berte","year":"1959","journal-title":"Dis Chest"},{"key":"10.1378\/chest.99.2.465_bib8","first-page":"598","article-title":"Isoniazid para-aminosalicylic acid, and streptomycin tolerance in 1744 patients: an analysis of reactions to single drugs and drug groups plus data on multiple reactions, type and time of reactions and desensitization","volume":"90","author":"Berte","year":"1964","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib9","first-page":"558","article-title":"Chemoprophylaxis for the prevention of tuberculosis; a statement by an ad-hoc committee","volume":"96","year":"1965","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib10","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.7326\/0003-4819-71-6-1113","article-title":"Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid","volume":"71","author":"Scharer","year":"1969","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.99.2.465_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1164\/arrd.1972.106.3.357","article-title":"Isoniazid-associated hepatitis: report of an outbreak","volume":"106","author":"Garibaldi","year":"1972","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/arrd.1971.104.3.454","article-title":"Report of the Ad Hoc Committee on Isoniazid and Liver Disease, Center for Disease Control, Department of Health, Education, and Welfare, March 17-18, 1971: Isoniazid and Liver Disease","volume":"104","year":"1971","journal-title":"Am Rev Resp Dis"},{"key":"10.1378\/chest.99.2.465_bib13","first-page":"991","article-title":"Isoniazid-related hepatitis. A US Public Health Service Cooperative Surveillance Study","volume":"117","author":"Kopanoff","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib14","first-page":"64","article-title":"Isoniazid prophylaxis and deaths in Baltimore","volume":"24","author":"Levin","year":"1974","journal-title":"Maryland State Med J"},{"key":"10.1378\/chest.99.2.465_bib15","first-page":"573","article-title":"The competing risks of tuberculosis and hepatitis for adult tuberculin reactors. Editorial","volume":"111","author":"Comstock","year":"1975","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib16","first-page":"393","article-title":"Jaundice occurring during treatment with rifampicin","volume":"33","author":"Lesobre","year":"1969","journal-title":"Rev Tuberc"},{"key":"10.1378\/chest.99.2.465_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0007-0971(70)80034-1","article-title":"Jaundice after rifampicin","volume":"64","author":"Lees","year":"1970","journal-title":"Br J Dis Chest"},{"key":"10.1378\/chest.99.2.465_bib18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/bmj.1.5793.148","article-title":"Effect of rifampicin and isoniazid on liver function","volume":"1","author":"Lal","year":"1972","journal-title":"Br Med J"},{"key":"10.1378\/chest.99.2.465_bib19","first-page":"461","article-title":"Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis","volume":"118","author":"Gronhagen-Riska","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0041-3879(80)90060-4","article-title":"Side effects of drug regimens used in short-course chemotherapy for pulmonary tuberculosis. A controlled clinical study","volume":"61","author":"Zierski","year":"1980","journal-title":"Tubercle"},{"key":"10.1378\/chest.99.2.465_bib21","first-page":"573","article-title":"Six-month isoniazid-rifampin therapy for pulmonary tuberculosis. Report of a United States Health Service Cooperative Trial","volume":"129","author":"Snider","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0002-9343(84)90697-1","article-title":"Short-course chemotherapy for tuberculosis with mainly twice weekly isoniazid and rifampin. Community physicians seven-year experience with mainly outpatients","volume":"77","author":"Dutt","year":"1984","journal-title":"Am J Med"},{"key":"10.1378\/chest.99.2.465_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0041-3879(77)90022-8","article-title":"The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide","volume":"59","author":"Girling","year":"1978","journal-title":"Tubercle"},{"key":"10.1378\/chest.99.2.465_bib24","first-page":"119","article-title":"Short-course chemotherapy in pulmonary tuberculosis","volume":"1","year":"1975","journal-title":"Lancet"},{"key":"10.1378\/chest.99.2.465_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1378\/chest.61.6_Supplement.587","article-title":"Hepatotoxicity in rifampin-isoniazid treated patients related to their rate of isoniazid inactivation","volume":"61","author":"Smith","year":"1972","journal-title":"Chest"},{"key":"10.1378\/chest.99.2.465_bib26","first-page":"349","article-title":"Rifampin-isoniazid therapy of alcoholic and nonalcoholic tuberculosis patients in a US Public Health Service Cooperative Therapy Trial","volume":"122","author":"Cross","year":"1980","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib27","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0041-3879(71)90041-9","article-title":"Toxicity from rifampin plus isoniazid and rifampicin plus ethambutol therapy","volume":"52","author":"Lees","year":"1971","journal-title":"Tubercle"},{"key":"10.1378\/chest.99.2.465_bib28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00006454-198505000-00013","article-title":"Hepatotoxic reactions in children with severe tuberculosis treated with isoniazid-rifampin","volume":"4","author":"Tsagaropoulou-Stinga","year":"1985","journal-title":"Pediatr Infect Dis."},{"key":"10.1378\/chest.99.2.465_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0016-5085(77)80088-7","article-title":"Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction","volume":"72","author":"Pessayre","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1378\/chest.99.2.465_bib30","first-page":"97","article-title":"Controlled clinical trial of a 3-month and two 5-month regimens in pulmonary tuberculosis. Second Madras short-course study","volume":"58","author":"Tripathy","year":"1983","journal-title":"Bull Int Union Tuberc"},{"key":"10.1378\/chest.99.2.465_bib31","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1164\/arrd.1978.118.4.794","article-title":"Isoniazid hepatotoxicity in children","volume":"118","author":"Rapp","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib32","first-page":"741","article-title":"Heaptic toxcity during chemotherapy for severe tuberculous meningitis","volume":"141","author":"Donald","year":"1987","journal-title":"Am J Dis Child"},{"key":"10.1378\/chest.99.2.465_bib33","first-page":"119","article-title":"Hepatotoxicity of isoniazid and rifampin in children","volume":"21","author":"Rugmini","year":"1984","journal-title":"Indian Pediatrics"},{"key":"10.1378\/chest.99.2.465_bib34","first-page":"589","article-title":"Adverse drug reactions among children treated for tuberculosis","volume":"29","year":"1980","journal-title":"MMWR"},{"key":"10.1378\/chest.99.2.465_bib35","first-page":"133","article-title":"Isoniazid hepatitis in adolescents","volume":"89","author":"Litt","year":"1976","journal-title":"Pediatric Pharmacology and Therapeutics"},{"key":"10.1378\/chest.99.2.465_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0041-3879(79)90006-0","article-title":"The treatment of tuberculous meningitis in children with a combination of isoniazid, rifampicin, and streptomycin: Preliminary report","volume":"60","author":"Rahajoe","year":"1979","journal-title":"Tubercle"},{"key":"10.1378\/chest.99.2.465_bib37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0041-3879(86)90003-6","article-title":"Hepatic toxicity in South Indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide","volume":"67","author":"Parthasarathy","year":"1986","journal-title":"Tubercle"},{"key":"10.1378\/chest.99.2.465_bib38","first-page":"963","article-title":"Isoniazid, rifampin, and hepatotoxicity","volume":"133","author":"Gangadharam","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods for combining randomized clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"key":"10.1378\/chest.99.2.465_bib40","first-page":"124","article-title":"Confidence intervals and hypothesis testing","author":"Woodson","year":"1987"},{"key":"10.1378\/chest.99.2.465_bib42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00004836-198109000-00012","article-title":"Risk factors for isoniazid-induced liver dysfunction","volume":"3","author":"Dickinson","year":"1981","journal-title":"J Clin Gastroenterol"},{"key":"10.1378\/chest.99.2.465_bib43","first-page":"58","article-title":"Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberuclosis","volume":"129","author":"Gurumurthy","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib44","first-page":"203","article-title":"Hepatitis cases in isoniazid treated groups and in a control group","volume":"51","author":"Riska","year":"1976","journal-title":"Bull Int Union Tuberc"},{"key":"10.1378\/chest.99.2.465_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0041-3879(73)90031-7","article-title":"Co-operative controlled trial of a standard regimen of streptomycin, PAS and isoniazid and three alternative regimens of chemotherapy in Britain","volume":"54","year":"1973","journal-title":"Tubercle"},{"key":"10.1378\/chest.99.2.465_bib46","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1378\/chest.61.6_Supplement.533","article-title":"Rifampin-isoniazid compared with PAS-isoniazidstreptomycin in initial treatment of pulmonary tuberculosis","volume":"61","author":"Bowman","year":"1972","journal-title":"Chest"},{"key":"10.1378\/chest.99.2.465_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0041-3879(74)90004-X","article-title":"Serum enzyme changes in patients receiving anti-tuberculosis therapy with rifampicin or p-aminosalicylic acid, plus isoniazid and streptomycin","volume":"55","author":"Baron","year":"1964","journal-title":"Tubercle"},{"key":"10.1378\/chest.99.2.465_bib48","first-page":"216","article-title":"Rifampin in initial treatment of pulmonary tuberculosis. A United States Public Health Service Therapy Trial","volume":"109","author":"Newman","year":"1974","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib49","first-page":"397","article-title":"Rifampin in treatment of advanced pulmonary tuberuclosis","volume":"105","author":"Raleigh","year":"1973","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib53","first-page":"579","article-title":"Clinical trial of six months and four months regimens of chemotherapy in the treatment of pulmonary tuberculosis in Singapore","volume":"119","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib54","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/bmj.3.5770.343","article-title":"Potentially serious side effects of high-dose twice-weekly rifampicin","volume":"3","author":"Poole","year":"1971","journal-title":"Br Med J"},{"key":"10.1378\/chest.99.2.465_bib55","first-page":"807","article-title":"Controlled trial of intermittent regimen of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore: the results up to 30 months","volume":"116","year":"1977","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib56","first-page":"727","article-title":"Controlled trial of 6-month and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong","volume":"115","year":"1977","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib57","first-page":"219","article-title":"Clinical trial of six months and eight month regimens of chemotherapy in the treatment of pulmonary tuberuclosis. First report","volume":"118","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib63","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJM198506063122304","article-title":"Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes","volume":"312","author":"Stead","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.99.2.465_bib64","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0016-5085(19)32568-5","article-title":"Isoniazid-associated hepatitis in 114 patients","volume":"69","author":"Black","year":"1975","journal-title":"Gastroenterology"},{"key":"10.1378\/chest.99.2.465_bib65","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/cpt197518170","article-title":"Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydrazine metabolites","volume":"18","author":"Mitchell","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"10.1378\/chest.99.2.465_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-79-1-1","article-title":"Isoniazid hepatitis","volume":"70","author":"Maddrey","year":"1973","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.99.2.465_bib67","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1378\/chest.68.2.181","article-title":"Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy","volume":"68","author":"Mitchell","year":"1975","journal-title":"Chest"},{"key":"10.1378\/chest.99.2.465_bib68","first-page":"118","article-title":"Clinical studies with a new rifamycin derivative","volume":"9","author":"Cohn","year":"1969","journal-title":"J Clin Pharm"},{"key":"10.1378\/chest.99.2.465_bib69","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/gut.13.5.366","article-title":"Effect of rifampicin on liver function in man","volume":"13","author":"Capelle","year":"1972","journal-title":"Gut"},{"key":"10.1378\/chest.99.2.465_bib70","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/bmj.2.5917.481","article-title":"Hepatorenal failure with self-initiated intermittent rifampicin therapy","volume":"2","author":"Rothwell","year":"1974","journal-title":"Br Med J"},{"key":"10.1378\/chest.99.2.465_bib71","first-page":"131","article-title":"Rifampin","author":"Loudon","year":"1974"},{"key":"10.1378\/chest.99.2.465_bib72","first-page":"394","article-title":"Human acetylation polymorphism. J Lab","volume":"63","author":"Price-Evans","year":"1964","journal-title":"Clin Med"},{"key":"10.1378\/chest.99.2.465_bib73","first-page":"364","article-title":"Pharmacokinetics of isoniazid metabolism in man","volume":"213","author":"Ellard","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1378\/chest.99.2.465_bib74","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/0003-4819-84-2-181","article-title":"Isoniazid liver injury: clinical spectrum, pathology and probable pathogenesis","volume":"84","author":"Mitchell","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.99.2.465_bib75","first-page":"628","article-title":"The hepatic toxicity of isoniazid among rapid acetylators of the drug [letter]","volume":"118","author":"Ellard","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib76","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/096032718500400210","article-title":"Plasma hydrazine concentrations in man after isoniazid and hydralazine administration","volume":"4","author":"Blair","year":"1985","journal-title":"Hum Toxicol"},{"key":"10.1378\/chest.99.2.465_bib77","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0041-3879(89)90033-0","article-title":"Isoniazid-related hepatotoxcity: a study of the effect of rifampicin administration on the metabolism of acetylisoniazid in man","volume":"70","author":"Ellard","year":"1989","journal-title":"Tubercle"},{"key":"10.1378\/chest.99.2.465_bib41","series-title":"Primer of biostatistics","first-page":"101","article-title":"How to analyze rates and proportions","author":"Glantz","year":"1987"},{"key":"10.1378\/chest.99.2.465_bib50","first-page":"1","article-title":"A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong","volume":"55","year":"1974","journal-title":"Tubercle"},{"key":"10.1378\/chest.99.2.465_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-3879(75)90003-3","article-title":"A comparative study of daily followed by twice or once weekly regimens of ethambutol and rifampicin retreatment of patients with pulmonary tuberculosis","volume":"56","year":"1975","journal-title":"Tubercle"},{"key":"10.1378\/chest.99.2.465_bib52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0041-3879(75)90050-1","article-title":"A controlled trial of daily and intermittent rifampicin plus ethambutol in the treatment of patients with pulmonary tuberculosis; results up to 30 months","volume":"56","year":"1975","journal-title":"Tubercle"},{"key":"10.1378\/chest.99.2.465_bib58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/adc.54.1.65","article-title":"Isoniazid liver injury during chemoprophylaxis in children","volume":"54","author":"Spyridis","year":"1979","journal-title":"Arch Dis Child"},{"key":"10.1378\/chest.99.2.465_bib59","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00006454-198909000-00019","article-title":"Incidence of hepatotoxicity in children receiving isoniazid chemoprophylaxis","volume":"8","author":"Nakajo","year":"1989","journal-title":"Pediatr Infec Dis J"},{"key":"10.1378\/chest.99.2.465_bib60","first-page":"581","article-title":"Liver enzyme disturbances during isoniazid chemoprophylaxis in children","volume":"110","author":"Beaudry","year":"1974","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.99.2.465_bib61","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1542\/peds.72.4.491","article-title":"Hepatotoxicity from isoniazid plus rifampin among children treated for tuberculosis","volume":"72","author":"O'Brien","year":"1983","journal-title":"Pediatrics"},{"key":"10.1378\/chest.99.2.465_bib62","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0022-3476(89)80157-X","article-title":"Tuberculous meningitis in children: treatment with isoniazid and rifampicin for twelve months","volume":"114","author":"Visudhiphan","year":"1989","journal-title":"J Pediatr"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216488586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216488586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T17:11:41Z","timestamp":1684084301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216488586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,2]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1991,2]]}},"alternative-id":["S0012369216488586"],"URL":"https:\/\/doi.org\/10.1378\/chest.99.2.465","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1991,2]]}}}